European Journal of Gynaecological Oncology
Print ISSN: 0392-2936 | Online ISSN: 2709-0086
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encourage the submission of systematic reviews and meta-analyses.
Articles
Prophylactic HPV vaccines reduce recurrence rates after conization of CIN: a clinical research review
Prophylactic HPV vaccines reduce recurrence rates after conization of CIN: a clinical research review
DOI: 10.22514/ejgo.2025.090
A United Kingdom national survey of pre-operative imaging and lymph node staging practices in early-stage endometrioid endometrial carcinoma
A United Kingdom national survey of pre-operative imaging and lymph node staging practices in early-stage endometrioid endometrial carcinoma
DOI: 10.22514/ejgo.2025.091
Patients with cervical cancer may under-report physical and emotional symptoms: a mixed-methods study of symptoms and quality-of-life to inform palliative care needs
Patients with cervical cancer may under-report physical and emotional symptoms: a mixed-methods study of symptoms and quality-of-life to inform palliative care needs
DOI: 10.22514/ejgo.2025.092
(This article belongs to the Special Issue Quality of Life in Gynecologic Malignancies )
Expression and clinical significance of CSAD in type I endometrial carcinoma
Expression and clinical significance of CSAD in type I endometrial carcinoma
DOI: 10.22514/ejgo.2024.110
Clinicopathological features and oncological prognosis in ovarian metastasis of the primary origin: a single-center retrospective study
Clinicopathological features and oncological prognosis in ovarian metastasis of the primary origin: a single-center retrospective study
DOI: 10.22514/ejgo.2025.094
Identification of a novel targeting peptide for cervical clear cell adenocarcinoma by in vivo phage display screening combined with immunofluorescent analysis
Identification of a novel targeting peptide for cervical clear cell adenocarcinoma by in vivo phage display screening combined with immunofluorescent analysis
DOI: 10.22514/ejgo.2025.095
Establishment of a predictive survival prognosis model for epithelial ovarian cancer: a study based on the SEER database
Establishment of a predictive survival prognosis model for epithelial ovarian cancer: a study based on the SEER database
DOI: 10.22514/ejgo.2025.097
Awareness, attitudes and vaccination intentions regarding cervical cancer and HPV among healthcare workers
Awareness, attitudes and vaccination intentions regarding cervical cancer and HPV among healthcare workers
DOI: 10.22514/ejgo.2025.098
Knockdown of PIMREG modulates the Wnt/β-catenin pathway to suppress proliferation and stemness in endometrial cancer
Knockdown of PIMREG modulates the Wnt/β-catenin pathway to suppress proliferation and stemness in endometrial cancer
DOI: 10.22514/ejgo.2025.099
Echinacoside suppresses cervical cancer by inhibiting cell growth and angiogenesis
Echinacoside suppresses cervical cancer by inhibiting cell growth and angiogenesis
DOI: 10.22514/ejgo.2025.100
Integrating chemoradiotherapy and nivolumab in advanced cervical cancer: two case reports
Integrating chemoradiotherapy and nivolumab in advanced cervical cancer: two case reports
DOI: 10.22514/ejgo.2025.101
A case series of four patients with recurrent ovarian granulosa cell tumors treated with CDK4/6 inhibitors and estrogen blockade in a pilot study
A case series of four patients with recurrent ovarian granulosa cell tumors treated with CDK4/6 inhibitors and estrogen blockade in a pilot study
DOI: 10.22514/ejgo.2025.102
(This article belongs to the Special Issue Advances in Ovarian Cancer Research)
Rare presentation of cervical choriocarcinoma with metastasis: a case report
Rare presentation of cervical choriocarcinoma with metastasis: a case report
DOI: 10.22514/ejgo.2025.103
Published Ahead of Print
Special Issues
Quality of Life in Gynecologic Malignancies
Keywords: Quality of life; Palliative care; Symptom management
Editor: Lori Spoozak, MD
Submission deadline: 31 December 2024
Endometrial Cancer and Fertility Preservation in the Denatality ERA
Keywords: Endometrial cancer; Fertility preservation; Surgery fertility sparing; Ovarian reserve
Editor: Dr. Giuseppe Gullo, MD, PhD,Dr. Alessandra Lopez, MD,Dr. Valentina Billone, MD, PhD St.
Submission deadline: 31 December 2025
Advances in Ovarian Cancer Research
Keywords: Ovarian cancer; Cytoreductive surgery; Recurrent ovarian cancer; Retroperitoneal lymphadenectomy; Women cancer global variation
Editor: Basel Refky, MD
Submission deadline: 31 July 2025
Current Update in the Treatment of Cervical Cancer
Keywords: Radical Hysterectomy; Fertility Sparing; Oncological Outcomes
Editor: Carlo Ronsini, MD
Submission deadline: 31 December 2025
Gynecological Cancer Prevention: A New Prospective
Keywords: Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology
Editor: Ottavia Dʼoria, MD
Submission deadline: 31 October 2023
Molecular Pathological Approach to Uterine Mesenchymal Tumors and Malignant Tumors for the Establishment of New Diagnostic and Therapeutic Methods
Keywords: Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer
Editor: Prof. Takuma Hayashi
Submission deadline: 31 October 2023
Molecular Characterization in Endometrial Cancer: Progress and Prospects
Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine
Editor: Andrea Giannini, MD, PhD
Submission deadline: 31 December 2022
Immunotherapy for Gynecological Oncology
Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer
Editor: Tadahiro Shoji, MD
Submission deadline: 31 July 2021
Enhanced Recovery of Gynecological Oncology
Keywords: Gynecological Cancer; Enhanced Recovery After Surgery; Minimally Invasive Surgery; Pain Management; Nutritional Support; High Quality Nursing; Psychological Counseling; Complication Management
Editor: Lin Li, MD
Submission deadline: 31 December 2022
Molecular Markers in Ovarian Cancer: Roles in Diagnosis, Prognostic Prediction, and Personalized Therapy
Keywords: Ovarian Cancer;Diagnosis;Prognosis;Treatment Response;Personalized Therapy;Platinum Resistance;Homologous Recombination Deficiency;Immunotherapy;Cytoreduction;Proteomics;Genomics;Prognostic Biomarkers;Diagnostic Biomarkers
Editor: Sharad Ghamande, MD,David Mysona, MD
Submission deadline: 30 March 2022
Featured Article
Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181
To Be a Reviewer
If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.
Review for EJGOJoin Editorial Board
You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.
Join Editorial BoardEditor-in-Chief
Prof. Enrique Hernandez, MD, FACOG, FACS.
Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.